The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.
暂无分享,去创建一个
L. Cosmi | F. Annunziato | F. Liotta | P. Campi | E. Maggi | S. Romagnani | F. Brugnolo | P. Parronchi | C. Manuelli | S. Sampognaro